Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC. Simiene J, Dabkeviciene D, Stanciute D, Prokarenkaite R, et al. BMC Cancer 2023;23:857.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Simiene J, Dabkeviciene D, Stanciute D, Prokarenkaite R, et al. Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC. BMC Cancer 2023;23:857.
PMID: 37697308